Strengthening the Opposition to Female Genital Mutilation Act of 2020
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
96pct
306d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Strengthening the Opposition to Female Genital Mutilation Act of 2020 or the STOP FGM Act of 2020 This bill revises the federal criminal statute that prohibits certain conduct often referred to as female genital mutilation (FGM). Currently, the FGM statute prohibits performing certain procedures—circumcising, excising, or infibulating the female genitalia of a minor—for nonmedical purposes. However, it does not define FGM. In 2018 a federal district court invalidated the FGM statute in United States vs. Nagarwala . The court found, among other things, that the statute exceeds Congress's authority under the Commerce Clause of the Constitution because it (1) lacks detailed, record-based findings regarding how FGM substantially affects interstate commerce; and (2) lacks jurisdictional elements (e.g., requirements that charged offenses have an explicit connection with, or effect on, interstate commerce). In 2019, the Department of Justice (DOJ) decided not to appeal the decision. This bill creates a statutory definition of female genital mutilation and provides explicit findings regarding the effects of FGM on interstate commerce. The bill broadens the scope of prohibited FGM-related conduct on a minor to include attempting or conspiring to perform FGM; facilitating or consenting to FGM, as a parent, guardian, or caretaker; and transporting a minor for FGM. It expressly requires prohibited FGM-related conduct to have a connection to interstate or foreign commerce. The bill increases from 5 to 10 years the statutory maximum prison term for an FGM offense. It also prohibits a federal criminal defendant from asserting, as a defense, that FGM is required as a matter of religion, custom, tradition, ritual, or standard practice. DOJ, in consultation with various federal agencies, must report annually on FGM, including the estimated number of women and girls at risk of or subjected to FGM and actions taken by government agencies to combat the practice. Finally, the bill expresses the sense of Congress that the court erred in invalidating the existing statute. It expresses, among other sentiments, that Congress elects to amend the statute to clarify the commercial nature of FGM, but that Congress does not ratify the interpretation of the federal district court in Nagarwala .
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2020 · fourth_quarter · Religion
HR 1450 - Do No Harm Act FY 2021 - Appropriations HR 2214 & S1123 - No BAN Act HR 1709 & S. 775 - Scientific Integrity Act HR 6100 - STOP FGM Act of 2020 HR 2975 - Women's Health Protection Act
Client expense: Not reported · Firm income: $10,000
Became Public Law No: 116-309.
Became Public Law No: 116-309.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Message on Senate action sent to the House.
Passed Senate without amendment by Unanimous Consent.
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
Senate Committee on the Judiciary discharged by Unanimous Consent. (consideration: CR S7509)
Senate Committee on the Judiciary discharged by Unanimous Consent.(consideration: CR S7509)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Religion
HR 1450 - Do No Harm Act FY 2021 - Appropriations HR 2214 & S1123 - No BAN Act HR 1709 & S. 775 - Scientific Integrity Act HR 6100 - STOP FGM Act of 2020 HR 2975 - Women's Health Protection Act
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Law Enforcement/Crime/Criminal Justice
Lobbied House and Senate against the STATES Act, H.R.2093/S.1028 Lobbied House for changes to H.R 6100, the STOP FGM Act Lobbied Senate in favor of S. Res 494, Denounce FGM Resolution
Client expense: $22,000 · Firm income: Not reported
Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office
2020 · first_quarter · Law Enforcement/Crime/Criminal Justice
Lobbied House and Senate against the STATES Act, H.R.2093/S.1028 Lobbied House for changes to H.R 6100, the STOP FGM Act Lobbied Senate in favor of S. Res 494, Denounce FGM Resolution
Client expense: $22,000 · Firm income: Not reported
Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), White House Office
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4589-4590)
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
DEBATE - The House proceeded with forty minutes of debate on H.R. 6100.
Considered under suspension of the rules. (consideration: CR H4589-4592)
Ms. Jackson Lee moved to suspend the rules and pass the bill, as amended.
Placed on the Union Calendar, Calendar No. 406.
Reported by the Committee on Judiciary. H. Rept. 116-506.
Congress.gov source codes: 5000, H12200
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the House Committee on the Judiciary.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| Markup by |
| March 11, 2020 |
| Judiciary Committee | House | Referred to | March 5, 2020 |
| September 16, 2020 |
| Introduced in House | March 5, 2020 |
| Enrolled Bill | -- |